Safety Alerts & Recalls
What does this mean?
This recall for Levothyroxine Sodium Tablets, 150 mcg from UDL Laboratories Inc. was issued at a warehouse and pharmacy level only. The FDA and the manufacturer have determined that any recalled product that may have been dispensed to patients does not pose a significant health risk. If you take Levothyroxine Sodium Tablets, 150 mcg packaged in blister units, labeled with the lot number OA432, please speak to your doctor if you think you are experiencing side effects or if you have other concerns about your medicine.
UDL Laboratories, Inc. Recalls Single Lot of Levothyroxine Sodium Tablets, 150 mcg
UDL Laboratories Inc. has recalled a single lot of Levothyroxine Sodium Tablets, 150 mcg sold in blister packs. Lot number OA432 has been recalled because routine testing found that the amount of active ingredient was too low in several samples from this lot.
Levothyroxine is used in the treatment of thyroid disorders. Levothyroxine is also sold under the brand names Levo-T, Levoxyl, Levothroid, Synthroid, Tirosint, and Unithroid. No other lots, strengths, or brands of Levothyroxine were involved in this recall.
To view the FDA notice about this recall, please visit: more information here